Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
Corona Gary Louis
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-08-03
|
3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [MDT]
|
|
(Last)
|
(First)
|
(Middle)
|
|
710 MEDTRONIC PARKWAY
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
Interim CFO /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
|
MINNEAPOLIS
|
MN
|
55432
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Corona Gary Louis
710 MEDTRONIC PARKWAY
MINNEAPOLIS, MN55432
|
|
|
Interim CFO
|
|
Signatures
|
/s/ Thomas L. Osteraas, attorney-in-fact
|
2024-08-12
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
Includes 432 shares purchased pursuant to Medtronic's Employee Stock Ownership Plan.
|
|
(2)
|
Includes 6,438 restricted stock units that vest in three annual installments beginning on December 6, 2024; 4,249 restricted stock units that vest on July 10, 2025; 1,298 restricted stock units that vest on July 31, 2026; and 6,250 restricted stock units that vest on July 29, 2027.
|
|
(3)
|
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
|
|
(4)
|
The performance share units vest on April 24, 2026.
|
|
(5)
|
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,245 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
|
|
(6)
|
Each performance share unit represented a contingent right to receive one share of Medtronic common stock.
|
|
(7)
|
The performance share units vest on December 6, 2026.
|
|
(8)
|
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,125 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
|
|
(9)
|
The performance share units vest on April 30, 2027.
|
|
(10)
|
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 6,250 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
